ACCESS SOLUTIONS

Global Access

Tanner bridges the gap between pharmaceutical companies and patients and physicians seeking access to new treatment options.

HOW IT WORKS

Expanding access across borders is what we do

International inquiries are our expertise, and our network of direct relationships with pharmaceutical companies allows us addresses these needs seamlessly and efficiently. Named Patient Programs are the primary mechanism we leverage to provide global access. Whether requests come from tenders as a result of drug shortages or for other reasons, we help provide access to products that are unlicensed or unregistered in the country where the patient is located. We always confirm the validity of the request and ensure the secure delivery of the product to the intended patient.

Contact Us

OUR APPROACH

The Named Patient Supply Process

The Named Patient Supply Process

The Named Patient Supply Process

OUR ACCESS SOLUTIONS

From Early-Access to Compassionate Use, we take a comprehensive approach to access solutions.

  1. Expanded Access Programs

    US FDA regulated pathways that allow provision of investigational new drugs (INDs) to patients with serious diseases or conditions who have exhausted approved therapy and cannot participate in a clinical trial.

  2. Compassionate Use

    The use of a new, unapproved drug to treat a seriously ill patient when no other treatments are available.

  3. Post-trial Supply

    A program to maintain supply of the medicine to patients until it becomes commercially available.

  4. Early Access Programs

    Allow pre-approval access to medicines for certain patients

  5. Donation Programs

    Programs for pharmaceutical companies that are seeking to donate their medicines in low- and middle-income countries where patients do not have the insurance or financial means to pay for them.

  6. Drug Shortages

    A service that sets up the infrastructure to respond to supply chain disruptions that can cause drug shortages and mitigate the impact on patient access to their medicines.

  7. Market Withdrawals

    Providing ways to access a market post-withdrawal where demand from physicians and patients remain, and we can help.

  8. Global Access

    We have the ability to access all products for request internationally – finding access to products in unmet demand of markets of need. We do this through NPP (processed through import).

  9. Clinical Supply Gatekeeper

    We can help you effectively manage inbound requests for comparators and reference listed drugs.

Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.